La Jolla, CA, United States of America

William Drell

This inventor holds 1 USPTO granted patent. Top assignee: Calbiochem-Behring Corp.. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Drell. Retrieved from https://idiyas.com/inventor/william-drell-lvs4av0h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William Drell

Introduction

William Drell is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of medicine, particularly in the area of therapeutic compositions. His work focuses on addressing health issues that affect many individuals.

Latest Patents

William Drell holds a patent for a process aimed at mitigating cholelithiasis. This therapeutic composition is useful for alleviating cholelithiasis in humans and comprises 3-hydroxy-3-methylglutaric acid, or a pharmaceutically acceptable salt thereof, along with a pharmaceutically acceptable non-toxic carrier. This innovation showcases his commitment to improving human health through scientific advancements.

Career Highlights

Drell is associated with Calbiochem-Behring Corporation, where he applies his expertise in developing innovative solutions. His work at the company has allowed him to contribute to significant advancements in therapeutic compositions.

Collaborations

William Drell has collaborated with John K Pollard, Jr., further enhancing the impact of his inventions. Their partnership exemplifies the importance of teamwork in the field of innovation.

Conclusion

William Drell's contributions to the field of medicine through his patent for mitigating cholelithiasis highlight his dedication to improving health outcomes. His work continues to inspire future innovations in therapeutic compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…